Literature DB >> 22116305

Molecular mechanism of interleukin-2-induced mucosal homeostasis.

Jayshree Mishra1, Christopher M Waters, Narendra Kumar.   

Abstract

Sustained damage to the mucosal lining in patients with inflammatory bowel disease (IBD) facilitates translocation of intestinal microbes to submucosal immune cells leading to chronic inflammation. Previously, we demonstrated the role of Jak3 in IL-2-induced intestinal epithelial cell (IEC) migration, one of the early events during intestinal wound repair. In this study, we demonstrate that IL-2 also plays a role in IEC homeostasis through concentration-dependent regulation of IEC proliferation and cell death. At lower concentrations (≤50 U/ml), IL-2 promoted proliferation, while at higher concentrations (100 U/ml), it promoted apoptosis. Activation by IL-2 led to tyrosine phosphorylation-dependent interactions between Jak3 and p52ShcA only at lower concentrations. Phosphatase SHP1 dephosphorylated IL-2-induced phosphorylated p52ShcA. Higher concentrations of IL-2 decreased the phosphorylation of Jak3 and p52ShcA, disrupted their interactions, redistributed Jak3 to the nucleus, and induced apoptosis in IEC. IL-2 also induced dose-dependent upregulation of p52shcA and downregulation of jak3-mRNA. Constitutive overexpression and mir-shRNA-mediated knockdown studies showed that expression of both Jak3 and p52ShcA were necessary for IL-2-induced proliferation of IEC. Doxycycline-regulated sh-RNA expression demonstrated that IL-2-induced downregulation of jak3-mRNA was responsible for higher IL-2-induced apoptosis in IEC. Collectively, these data demonstrate a novel mechanism of IL-2-induced mucosal homeostasis through posttranslational and transcriptional regulation of Jak3 and p52ShcA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22116305      PMCID: PMC3311301          DOI: 10.1152/ajpcell.00316.2011

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  50 in total

Review 1.  Cell adhesion receptors, tyrosine kinases and actin modulators: a complex three-way circuitry.

Authors:  V G Brunton; I R J MacPherson; M C Frame
Journal:  Biochim Biophys Acta       Date:  2004-07-05

2.  Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease.

Authors:  Y R Mahida; A Gallagher; L Kurlak; C J Hawkey
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

3.  Isolation of a src homology 2-containing tyrosine phosphatase.

Authors:  J Plutzky; B G Neel; R D Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

Review 4.  Healing the epithelium: solving the problem from two sides.

Authors:  D K Podolsky
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

5.  The conversion of redox status of peritoneal macrophages during pathological progression of spontaneous inflammatory bowel disease in Janus family tyrosine kinase 3(-/-) and IL-2 receptor gamma(-/-) mice.

Authors:  Yukie Murata; Akira Yamashita; Takashi Saito; Kazuo Sugamura; Junji Hamuro
Journal:  Int Immunol       Date:  2002-06       Impact factor: 4.823

6.  Immunolocalization of a new intestinal antiproliferative factor in human intestinal epithelial cells.

Authors:  Christian Lavagna; Carine Strup; Agnes Rampal; Paul Hofman; Sylvie Bardon; Patrick Rampal; Jean-Claude Poirée
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

Review 7.  Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease.

Authors:  Noah P Zimmerman; Rebecca A Vongsa; Michael K Wendt; Michael B Dwinell
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

8.  European trial of cyclosporine in chronic active Crohn's disease: a 12-month study. The European Study Group.

Authors:  E F Stange; R Modigliani; A S Peña; A J Wood; G Feutren; P R Smith
Journal:  Gastroenterology       Date:  1995-09       Impact factor: 22.682

9.  Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease.

Authors:  J Brynskov; N Tvede; C B Andersen; M Vilien
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

10.  T-2 toxin impairment of enteric reovirus clearance in the mouse associated with suppressed immunoglobulin and IFN-gamma responses.

Authors:  Maoxiang Li; Christopher F Cuff; James J Pestka
Journal:  Toxicol Appl Pharmacol       Date:  2006-02-28       Impact factor: 4.219

View more
  19 in total

1.  Training the Defense System for Modern-Day Warfare: The Horizons for Immunotherapy and Vaccines for Cancer.

Authors:  Narendra Kumar; Jayshree Mishra; Sohel H Quazi
Journal:  J immunodefic Disord       Date:  2012-07-21

2.  JANEX-1 improves acute pulmonary embolism through VEGF and FAK in pulmonary artery smooth muscle cells.

Authors:  Longfei Pan; Zhuo Peng; Ruipeng Zhang; Rui Zhang; Dean Liang; Heming Chen; Hongyan Tian
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-15

3.  Janus Kinase 3, a Novel Regulator for Smooth Muscle Proliferation and Vascular Remodeling.

Authors:  Yung-Chun Wang; Xiao-Bing Cui; Ya-Hui Chuang; Shi-You Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-05-04       Impact factor: 8.311

4.  Adapter protein Shc regulates Janus kinase 3 phosphorylation.

Authors:  Jayshree Mishra; Narendra Kumar
Journal:  J Biol Chem       Date:  2014-05-02       Impact factor: 5.157

5.  Identification of molecular switch regulating interactions of Janus kinase 3 with cytoskeletal proteins.

Authors:  Jayshree Mishra; Satya Sridhar Karanki; Narendra Kumar
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

Review 6.  Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis.

Authors:  Jayshree Mishra; Joseph Drummond; Sohel H Quazi; Satya Sridhar Karanki; J J Shaw; Ben Chen; Narendra Kumar
Journal:  Crit Rev Oncol Hematol       Date:  2012-10-23       Impact factor: 6.312

7.  Role of Janus kinase 3 in mucosal differentiation and predisposition to colitis.

Authors:  Jayshree Mishra; Raj K Verma; Gianfranco Alpini; Fanyin Meng; Narendra Kumar
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

Review 8.  Immune-epithelial crosstalk at the intestinal surface.

Authors:  Nadine Wittkopf; Markus F Neurath; Christoph Becker
Journal:  J Gastroenterol       Date:  2014-01-28       Impact factor: 7.527

Review 9.  JAK-STAT pathway targeting for the treatment of inflammatory bowel disease.

Authors:  Azucena Salas; Cristian Hernandez-Rocha; Marjolijn Duijvestein; William Faubion; Dermot McGovern; Severine Vermeire; Stefania Vetrano; Niels Vande Casteele
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-03-19       Impact factor: 46.802

10.  Role of Janus Kinase 3 in Predisposition to Obesity-associated Metabolic Syndrome.

Authors:  Jayshree Mishra; Raj K Verma; Gianfranco Alpini; Fanyin Meng; Narendra Kumar
Journal:  J Biol Chem       Date:  2015-10-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.